Early-Career Investigators Workshop (2021)
The Early-Career Investigators Workshop (ECIW) is held annually to foster career development in urologic research by providing participants with a solid foundation for successful grant writing. Activities include one-on-one mentoring sessions with scientific advisors; presentations on navigating federally-funded grant programs; mock peer review session; presentations on developing a fundable research program; and career development presentations. Approximately 30 nominees are selected to participate in the workshop.
Course Registration Fees
Category | Fee |
---|---|
AUA Member | $400 |
Non-Member | $500 |
No cancellation permitted without prior written permission from the AUA Office of Research. Please contact Julia Gumminger, Research Education and Events Manager at jgumminger@auanet.org with any questions.
Target Audience
- By invitation-only following a nomination and review process
- MD or MD, PhD urology researchers preparing to submit a major grant application
- PhD urology researchers preparing to submit a major grant application
Learning Objectives
At the conclusion of the workshop, participating early career investigators will be able to:
- Describe the cutting-edge and developing areas in basic and translational research, and identify components of their research efforts that intersect with or expand upon these;
- Develop and refine a compelling, innovative, and testable hypothesis;
- Develop a reasonable and ‘do-able’ experimental plan that adequately tests the stated hypothesis;
- Identify potential limitations of the proposed experimental plan and alternative experimental outcomes, and develop responsive alternative experimental approaches;
- Expand the initial concepts presented in the application to optimally project future directions, concepts, and studies;
- Avoid common pitfalls that typically dampen the enthusiasm of grant reviewers; and
- Describe the necessary administrative (nuts-and-bolts) components of NIH grant applications.
Minor changes to the agenda may occur leading up to the meeting.
Online Pre-Recorded Presentations
Welcome, Introductions, Program Overview | Carolyn J.M. Best, PhD |
Setting the Stage: An Overview of the State of Urology Research and Funding | Carolyn J.M. Best, PhD |
NIDDK Grant Mechanisms | Tracy Rankin, PhD, MPH |
NCI Career Development Grant Mechanisms | Susan Lim, PhD or Sergey Radaev, PhD |
VA Research Funding Opportunities | Kenute A. Myrie, PhD or Michael Burgio, PhD |
NIA Urologic Research Portfolio | Candace L. Kerr, PhD |
DoD Congressionally Directed Medical Research Programs: Funding Opportunities and Application Review | Theresa Miller, PhD |
American Cancer Society Research Programs | Ellie Daniels, MD, MPH |
AUA, Urology Care Foundation, and Other Grant Mechanisms | W. Taylor Monson, MA |
Identifying & Composing the Pieces of a Successful Research Grant Proposal | Erika Wolff, PhD |
Thursday, October 7, 2021
12:00 PM | Welcome, Introduction of Funding Agency Speakers | Carolyn Best, PhD |
12:15 PM | Live Q&A with Funding Agency Speakers | Moderator: Carolyn Best, PhD |
1:00 PM | Goal Setting and Introductions of Faculty and Participants | Carolyn Best, PhD |
1:45 PM | Specific Aims Workshop | Erika Wolff, PhD |
2:30 PM | Q&A | |
2:35 PM | Break | |
2:50 PM | Establishing Effective Career Development Goals and Translation to Your Training Plan | Peter Clark, MD |
3:05 PM | Q&A | |
3:10 PM | Building a Team of Mentors | Trinity Bivalacqua, MD, PhD |
3:25 PM | Q&A | |
3:30 PM | Common Grant Writing Pitfalls | Dolores Lamb, PhD, HCLD (ABB) |
3:45 PM | Q&A | |
3:50 PM | Break | |
4:05 PM | Importance of Social Networks and Serendipity in Scientific Discovery | Michael Hsieh, MD. PhD |
4:20 PM | Q&A | |
4:25 PM | The Importance of Translating Research into Clinical Impact | Margot Damaser, PhD |
4:40 PM | Q&A | |
4:45 PM | How to Start a Lab as a Junior Faculty | Ranjith Ramasamy, MD |
5:00 PM | Q&A | |
5:05 PM | Discussion, Wrap Up, and Day 2 Sneak Peek | |
5:30 PM | Adjourn for the Day |
Friday, October 8, 2021
12:00 PM | Day 2 Goal Setting and Introduction to Peer Review | Carolyn Best, PhD |
12:25 AM | Mock Peer Review Study Section | Faculty Panel - Chairperson: |
1) Funded K08 Application (PI redacted): “A Patient-Centered Approach to Integration of Life Expectancy into Treatment Decision-Making for Patients with Genitourinary Malignancy” | Primary Reviewer:John Gore, MD, MS Secondary Reviewer: Rosalyn Adam, PhD | |
2) NOT Funded K01 Application (PI redacted): “Mechanisms of Fatty Acid Metabolism in Prostate Differentiation and Disease” | Primary Reviewer: Trinity Bivalacqua, MD, PhD Secondary Reviewer: Peter Clark, MD | |
3) Funded R01 Application (PI redacted): “Improving Diagnosis of Congenital Genitourinary Anomalies” | Primary Reviewer: J. Todd Purves, MD, PhD Secondary Reviewer: Michael Hsieh, MD, PhD | |
2:15 PM | Q&A and Discussion - Briefing for Breakout Sessions and Plan for Tomorrow | See sticker on back of nametag for table assignment |
2:45 PM | Break and Transition to Breakout Groups (Early Group Members have a break until 4:15 PM) | |
3:00 PM | ADVANCED Grant Development Group: Individual Meetings with Faculty Mentors | |
Mentor | Advanced Group Mentee Dr. Gore | Dr. Nseyo Dr. Lamb | Dr. Shafi Dr. Wei | Dr. Giannitrapani Dr. Damaser | Dr. Sack Dr. Clark | Dr. Kregel Dr. Purves | Dr. Rowe Dr. Adam | Dr. Steadman Dr. Bivalacqua | Dr. Dondossola Dr. Hsieh | Dr. Ruthig Dr. Gore | Dr. Ristau (see below at 4:30 PM) | ||
4:15 PM | Break and Transition to Breakout Groups (Advanced Group Members have personal work time) | |
4:30 PM | EARLY Grant Development Group: Small Group Meetings with Faculty Mentors | Virtual Breakout Groups |
Mentor | Early Group Mentee Dr. Gore | Dr. Ristau (Advanced) Dr. Lamb | Dr. Fernandez Dr. Adam | Dr. Montalbetti Dr. Damaser | Dr. Waisanen Dr. Purves | Dr. Hill Dr. Wei | Dr. Bajic Dr. Bivalacqua | Dr. Matulay Dr. Clark | Dr. Lenis Dr. Hsieh | Dr. Weaver Dr. Chai | Dr. Propst and Dr. Wallace Dr. Ramasamy | Dr. Kang | ||
5:30 PM | Adjourn for the day |
Saturday, October 9, 2021
12:00 PM | Day 3 Goal Setting | Carolyn Best, PhD |
12:10 PM | Interpreting and Responding to Study Section Summary | J. Todd Purves, MD, PhD |
12:25 PM | Q&A | |
12:30 PM | Selling Yourself Through Your NIH Biosketch | Rosalyn Adam, PhD Boston Children's Hospital |
12:45 PM | Q&A |
|
12:50 PM | Project Management Techniques for Research | Erika Wolff, PhD University of Washington |
1:05 PM | Q&A | |
1:10 PM | Faculty Round Table Discussion: Virtual Breakouts for Faculty Feedback and Q&A | Faculty assigned to different breakout rooms, participants can self-select |
1:50 PM | Break and Transition to Main Session | |
2:00 PM | Advanced Grant Development Group: Presentations of Research Proposals (5 minutes per presentation) | Carolyn Best, PhD |
2:04 PM | Dr. Nseyo | |
2:10 PM | Dr. Shafi | |
2:16 PM | Dr. Giannitrapani | |
2:22 PM | Dr. Sack | |
2:28 PM | Dr. Kregel | |
2:34 PM | Dr. Rowe | |
2:40 PM | Dr. Steadman | |
2:46 PM | Dr. Dondossola | |
2:52 PM | Dr. Ruthig | |
2:58 PM | Dr. Ristau | |
3:04 PM | Faculty Feedback, Q&A, Closing Remarks | Carolyn Best, PhD and All Faculty |
3:45 PM | Adjourn |
Planner and Speaker Disclosures
Planner & Speaker Disclosures for ECIW 2021.pdf
COI Review Work Group Disclosures
COI Review Work Group Disclosures_2021_18.pdf
All relevant financial relationships have been mitigated.
AUA Staff has nothing to disclose.
ACCREDITATION:
The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CREDIT DESIGNATION:
The American Urological Association designates this live activity for a maximum of 13.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
OTHER LEARNERS:
The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.
EVIDENCE BASED CONTENT:
It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.
AUA DISCLOSURE POLICY:
All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.
RESOLUTION OF IDENTIFIED CONFLICT OF INTEREST:
All disclosures will be reviewed by the program/course directors or editors for identification of conflicts of interest. Peer reviewers, working with the program directors and/or editors, will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:
- Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director, editor, and/or Education Conflict of Interest Review Work Group or its subgroup.
- Limit content to evidence with no recommendations
- Introduction of a debate format with an unbiased moderator (point-counterpoint)
- Inclusion of moderated panel discussion
- Publication of a parallel or rebuttal article for an article that is felt to be biased
- Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
- Divestiture of the relationship by faculty
OFF-LABEL OR UNAPPROVED USE OF DRUGS OR DEVICES:
The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.
AUA PARTICIPANT INFORMATION & POLICIES
DISCLAIMER:
The opinions and recommendations expressed by faculty, authors and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the AUA.
CONSENT TO USE OF PHOTOGRAPHIC IMAGES:
Attendance at or participation in AUA meetings and other activities constitutes an agreement by the registrant to AUA's use and distribution (both now and in the future) of the attendee's image or voice in photographs and electronic reproductions of such meetings and activities.
REPRODUCTION PERMISSION:
Reproduction of written materials developed for this AUA course is prohibited without the written permission from individual authors and the American Urological Association.
SPECIAL ASSISTANCE:
The AUA complies with the Americans with Disabilities Act §12112(a). If any participant is in need of special assistance, please contact Julia Gumminger at jgumminger@auanet.org.
Available Credit
- 13.50 AMA PRA Category 1 Credit™
- 13.50 Non-Physician Participation
Price
Course Registration Fees
Category | Fee |
---|---|
AUA Member | $400 |
Non-Member | $500 |
No cancellation permitted without prior written permission from the AUA Office of Research. Please contact Julia Gumminger, Research Education and Events Manager at jgumminger@auanet.org with any questions.